Positron emission tomography and radiotherapy planning in lung cancer;Apport de la tomographie par émission de positons à la radiothérapie thoracique

Cancer/Radiotherapie

Volumn 4, Issue SUPPL. 1, 2000, Pages

  Vaylet, F ^a   Foehrenbach, H ^a   Guigay, J ^a   De Dreuille, O ^a   Maszelin, P ^a   Grassin, F ^a   Margery, J ^a   Dot, J M ^a   Gaillard, J F ^a   L'Her, P ^a  

^a Service des Maladies Respiratoires   (France)

Author keywords

Fluorodesoxyglucose; Lung cancer; PET; Radiotherapy; Radiotherapy planning

Indexed keywords

CANCER RADIOTHERAPY; CANCER RECURRENCE; CONFERENCE PAPER; DIAGNOSTIC VALUE; LUNG CANCER; LYMPH NODE METASTASIS; MINIMAL RESIDUAL DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR LOCALIZATION;

FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; RADIOGRAPHY, THORACIC; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034528050     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Les détecteurs de positons, Caméra PET-Caméra PET-SPECT
2. 18FDG) dans le suivi thérapeutique du cancer pulmonaire non petites cellules (CPNPC)
3. PET in lung cancer
4. Metastases from non-small cell lung cancer: Mediastinal staging in the 1990's: Meta-analytic comparison of PET and CT
5. Nuclear medicine in cancer diagnosis
6. Positron emission tomography imaging in the thorax
7. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings
8. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of the non small cell lung carcinoma
9. Positon emission tomography for mediastinal staging in non small cell lung cancer: A meta-analysis
10. Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: Preliminary findings
11. A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma
12. The contribution of 18F-fluoro-2-désoxyglucose positron emission tomographic imaging to radiotherapy planning in lung cancer
13. Imaging of hypoxia in humans tumors with [F-18]fluoromisonidazole
14. Comparison of dual-head coincidence imaging PET versus conventional ring PET in tumors patients
15. Multimodality nuclear medicine imging in three-dimensional radiation treatment planning for lung cancer: Challenge and prospects
16. 18F-désoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: High impact in patients with atelectasis
17. 18FDG en oncologie. Expérience préliminaire et revue de la littérature
18. The applications of PET in clinical oncology
19. Une révolution en pneumologie: La tomographie par émission de positons
20. Fluoro-deoxy-glucose et cancer bronchopulmpmonaire. Les premiers résultats français en caméra à positons
21. Métabolisme glucidique des cellules tumorales: Conséquences pour l'utilisation de radiopharmaceutiques analogues du glucose
22. Metabolic monitoring of breast cancer chemohormontherapy using positron emission tomography. Initial evaluation
23. On the metabolism of the tumors in the body
24. Imaging of lung cancer with fluorine - 18 fluorodeoxyglucose: Comparison of a dual-head camera in coincidence mode with a full-ring positon emission tomogmphy system
25. FDG PET in solitary pulmonary nodules: A german cost-effectiveness analysis